Elrexfio
NDC 63539-252, elranatamab-bcmm, injection, solution, from U.S. Pharmaceuticals.
- Product NDC
- 63539-252
- Status
- Listed
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761345
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63539-252 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELRANATAMAB44 mg/1.1mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63539-252-02 | 63539025202 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/aa044060-5b4b-4692-bf0f-9a50e140b10e
Use it
Look up 63539-252 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63539-252 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63539-252. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.